Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 76, Issue Suppl 2
OP0100 Overall cancer risk in patients with rheumatoid arthritis treated with tnf inhibitors, tocilizumab, abatacept, or rituximab
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Oral Presentations
Progress in biological treatment of RA
OP0100 Overall cancer risk in patients with rheumatoid arthritis treated with tnf inhibitors, tocilizumab, abatacept, or rituximab
Free
Online download statistics by month:
Online download statistics by month: June 2017 to March 2024
Abstract
Full
Pdf
Jun 2017
28
0
6
Jul 2017
66
0
8
Aug 2017
44
0
4
Sep 2017
90
0
7
Oct 2017
82
0
6
Nov 2017
48
0
3
Dec 2017
34
0
4
Jan 2018
34
0
0
Feb 2018
84
0
8
Mar 2018
61
0
4
Apr 2018
74
0
19
May 2018
72
0
3
Jun 2018
38
0
4
Jul 2018
88
0
2
Aug 2018
34
0
4
Sep 2018
48
0
4
Oct 2018
28
0
1
Nov 2018
24
0
6
Dec 2018
24
0
3
Jan 2019
15
0
4
Feb 2019
20
0
5
Mar 2019
31
0
4
Apr 2019
10
0
3
May 2019
10
0
4
Jun 2019
12
0
1
Jul 2019
16
0
3
Aug 2019
6
0
4
Sep 2019
7
0
0
Oct 2019
14
0
4
Nov 2019
8
0
2
Dec 2019
6
0
0
Jan 2020
5
0
2
Feb 2020
4
0
1
Mar 2020
28
0
2
Apr 2020
6
0
3
May 2020
8
0
2
Jun 2020
13
0
0
Jul 2020
6
0
2
Aug 2020
4
0
1
Sep 2020
16
0
1
Oct 2020
6
0
0
Nov 2020
2
0
1
Dec 2020
4
0
0
Jan 2021
0
0
2
Feb 2021
0
0
2
Mar 2021
7
0
2
Apr 2021
10
0
6
May 2021
0
0
1
Jun 2021
0
0
4
Jul 2021
0
0
3
Aug 2021
0
0
2
Sep 2021
1
0
3
Oct 2021
8
0
20
Nov 2021
2
0
5
Dec 2021
8
0
3
Jan 2022
8
0
1
Feb 2022
10
0
1
Mar 2022
6
0
2
Apr 2022
8
0
3
May 2022
16
0
6
Jun 2022
14
0
2
Jul 2022
20
0
1
Aug 2022
22
0
3
Sep 2022
10
0
6
Oct 2022
10
0
5
Nov 2022
4
0
1
Dec 2022
6
0
1
Jan 2023
8
0
3
Feb 2023
6
0
0
Mar 2023
29
0
0
Apr 2023
2
0
0
May 2023
8
0
4
Jun 2023
4
0
0
Jul 2023
6
0
3
Aug 2023
7
0
0
Sep 2023
11
0
0
Oct 2023
8
0
2
Nov 2023
12
0
1
Dec 2023
28
0
1
Jan 2024
4
0
1
Feb 2024
4
0
0
Mar 2024
8
0
5
Total
1573
0
250
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?